Production (Stage)
Replimune Group, Inc.
REPL
$8.98
-$0.39-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 55.87% | 30.86% | 4.94% | -5.28% | 8.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.62% | 16.96% | -7.70% | 3.03% | 11.46% |
| Operating Income | -35.62% | -16.96% | 7.70% | -3.03% | -11.46% |
| Income Before Tax | -34.63% | -29.85% | 11.93% | -8.95% | -12.64% |
| Income Tax Expenses | -64.62% | 21.56% | -- | -- | -122.57% |
| Earnings from Continuing Operations | -34.60% | -29.77% | 11.64% | -8.51% | -11.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.60% | -29.77% | 11.64% | -8.51% | -11.85% |
| EBIT | -35.62% | -16.96% | 7.70% | -3.03% | -11.46% |
| EBITDA | -35.11% | -17.13% | 8.05% | -2.85% | -11.24% |
| EPS Basic | 1.27% | -3.59% | 13.98% | -5.42% | -10.70% |
| Normalized Basic EPS | 1.26% | -3.64% | 14.27% | -5.85% | -11.48% |
| EPS Diluted | 1.27% | -3.59% | 13.98% | -5.42% | -10.70% |
| Normalized Diluted EPS | 1.26% | -3.64% | 14.27% | -5.85% | -11.48% |
| Average Basic Shares Outstanding | 36.34% | 25.29% | 2.72% | 2.93% | 1.04% |
| Average Diluted Shares Outstanding | 36.34% | 25.29% | 2.72% | 2.93% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |